Logo image of H6D0.DE

HALEON PLC (H6D0.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:H6D0 - GB00BMX86B70 - Common Stock

4.262 EUR
+0.05 (+1.19%)
Last: 1/14/2026, 7:00:00 PM

H6D0.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap18.98B
Revenue(TTM)11.23B
Net Income(TTM)1.44B
Shares4.45B
Float4.45B
52 Week High5.12
52 Week Low3.75
Yearly Dividend0.07
Dividend Yield1.83%
EPS(TTM)0.21
PE20.3
Fwd PE17.68
Earnings (Next)02-25
IPO2022-07-18
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
H6D0.DE short term performance overview.The bars show the price performance of H6D0.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 4

H6D0.DE long term performance overview.The bars show the price performance of H6D0.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 5 -5 10 15

The current stock price of H6D0.DE is 4.262 EUR. In the past month the price increased by 4.56%. In the past year, price decreased by -5.18%.

HALEON PLC / H6D0 Daily stock chart

H6D0.DE Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to H6D0.DE. When comparing the yearly performance of all stocks, H6D0.DE is a bad performer in the overall market: 69.42% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

H6D0.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to H6D0.DE. H6D0.DE has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

H6D0.DE Financial Highlights

Over the last trailing twelve months H6D0.DE reported a non-GAAP Earnings per Share(EPS) of 0.21. The EPS increased by 6.59% compared to the year before.


Industry RankSector Rank
PM (TTM) 12.84%
ROA 4.2%
ROE 8.92%
Debt/Equity 0.53
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%-5.33%
EPS 1Y (TTM)6.59%
Revenue 1Y (TTM)-0.61%

H6D0.DE Forecast & Estimates

24 analysts have analysed H6D0.DE and the average price target is 4.94 EUR. This implies a price increase of 15.89% is expected in the next year compared to the current price of 4.262.

For the next year, analysts expect an EPS growth of 5.74% and a revenue growth -1.32% for H6D0.DE


Analysts
Analysts79.17
Price Target4.94 (15.91%)
EPS Next Y5.74%
Revenue Next Year-1.32%

H6D0.DE Ownership

Ownership
Inst Owners58.32%
Ins Owners0.06%
Short Float %N/A
Short RatioN/A

About H6D0.DE

Company Profile

H6D0 logo image Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Weybridge, Surrey and currently employs 24,000 full-time employees. The company went IPO on 2022-07-18. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.

Company Info

HALEON PLC

Building 5, First Floor, The Heights

Weybridge SURREY GB

Employees: 24000

H6D0 Company Website

H6D0 Investor Relations

Phone: 441932822000

HALEON PLC / H6D0.DE FAQ

Can you describe the business of HALEON PLC?

Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Weybridge, Surrey and currently employs 24,000 full-time employees. The company went IPO on 2022-07-18. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.


Can you provide the latest stock price for HALEON PLC?

The current stock price of H6D0.DE is 4.262 EUR. The price increased by 1.19% in the last trading session.


Does HALEON PLC pay dividends?

HALEON PLC (H6D0.DE) has a dividend yield of 1.83%. The yearly dividend amount is currently 0.07.


How is the ChartMill rating for HALEON PLC?

H6D0.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Can you provide the market cap for HALEON PLC?

HALEON PLC (H6D0.DE) has a market capitalization of 18.98B EUR. This makes H6D0.DE a Large Cap stock.


What is the next earnings date for H6D0 stock?

HALEON PLC (H6D0.DE) will report earnings on 2026-02-25, after the market close.